SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZUCCHINI, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.318
AS - Asia 3.578
EU - Europa 2.934
SA - Sud America 514
AF - Africa 90
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.443
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.134
SG - Singapore 1.340
CN - Cina 965
PL - Polonia 681
VN - Vietnam 431
DE - Germania 419
RU - Federazione Russa 412
BR - Brasile 389
IT - Italia 304
UA - Ucraina 293
GB - Regno Unito 248
HK - Hong Kong 239
TR - Turchia 204
FI - Finlandia 196
FR - Francia 128
CA - Canada 105
JP - Giappone 90
IN - India 82
SE - Svezia 56
MX - Messico 50
AR - Argentina 49
BD - Bangladesh 41
ID - Indonesia 39
ES - Italia 38
ZA - Sudafrica 35
IQ - Iraq 33
CZ - Repubblica Ceca 28
AT - Austria 27
NL - Olanda 27
PK - Pakistan 24
EC - Ecuador 22
LT - Lituania 19
CO - Colombia 17
MA - Marocco 16
VE - Venezuela 14
BE - Belgio 13
CL - Cile 12
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 10
PH - Filippine 8
AU - Australia 7
EG - Egitto 7
IR - Iran 7
JO - Giordania 7
KE - Kenya 7
UZ - Uzbekistan 7
DO - Repubblica Dominicana 6
ET - Etiopia 6
JM - Giamaica 6
PT - Portogallo 6
DZ - Algeria 5
MY - Malesia 5
PA - Panama 5
RS - Serbia 5
BY - Bielorussia 4
IL - Israele 4
NP - Nepal 4
RO - Romania 4
TN - Tunisia 4
UY - Uruguay 4
AZ - Azerbaigian 3
CH - Svizzera 3
CR - Costa Rica 3
GE - Georgia 3
GR - Grecia 3
HN - Honduras 3
IE - Irlanda 3
KR - Corea 3
LB - Libano 3
NI - Nicaragua 3
OM - Oman 3
PY - Paraguay 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GT - Guatemala 2
KZ - Kazakistan 2
MD - Moldavia 2
NO - Norvegia 2
PE - Perù 2
SI - Slovenia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
DM - Dominica 1
EE - Estonia 1
GN - Guinea 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MN - Mongolia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
QA - Qatar 1
Totale 14.437
Salva come PNG Salva come JPEG
Città #
Ashburn 980
Singapore 863
Fairfield 683
Warsaw 670
Woodbridge 645
San Jose 466
Houston 394
Beijing 364
Chandler 343
Jacksonville 313
Santa Clara 285
Seattle 264
Ann Arbor 256
Wilmington 243
Hong Kong 237
Munich 204
Cambridge 198
Los Angeles 142
Ho Chi Minh City 135
New York 128
Ferrara 113
Hanoi 108
Nanjing 106
Izmir 104
Helsinki 100
Tokyo 89
Dallas 79
Princeton 71
San Diego 58
Shanghai 56
Lauterbourg 55
Milan 54
Orem 48
São Paulo 43
Boardman 39
Washington 36
Brooklyn 32
Buffalo 32
Council Bluffs 32
London 32
Turku 31
Montreal 30
Jakarta 29
Chennai 28
Chicago 28
Frankfurt am Main 28
Denver 26
Phoenix 26
Mexico City 25
Nanchang 25
Boston 24
Atlanta 23
Da Nang 22
Stockholm 22
Toronto 22
Hebei 21
Johannesburg 21
Poplar 21
Bologna 20
Moscow 19
Vienna 19
Falkenstein 18
Vancouver 18
Amsterdam 17
Brno 17
Jiaxing 17
Manchester 17
San Francisco 17
Norwalk 16
Shenyang 16
The Dalles 16
Auburn Hills 14
Haiphong 14
Hefei 14
Dearborn 13
Falls Church 13
Mcallen 13
Rio de Janeiro 13
Tianjin 13
Ankara 12
Baghdad 12
Montréal 12
Brussels 11
Mountain View 11
Nuremberg 11
Quito 11
Brasília 10
Bremen 10
Changsha 10
Mumbai 10
Columbus 9
Guangzhou 9
Hải Dương 9
Ningbo 9
San Mateo 9
Dong Ket 8
Guarulhos 8
Hangzhou 8
Istanbul 8
Lahore 8
Totale 10.091
Salva come PNG Salva come JPEG
Nome #
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats 554
Is autopsy tissue a valid control for epilepsy surgery tissue in microRNA studies? 406
Bystander effect on brain tissue of mesoangioblasts producing neurotrophins 384
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy - Comparison with human epileptic samples 378
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes 377
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 307
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 268
FGF-2 Overexpression Increases Excitability and Seizure Susceptibility but Decreases Seizure-Induced Cell Loss 267
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 243
A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression 242
Decreased levels of neuropeptide Y5 receptor binding sites in two experimental models of epilepsy 242
Alterations in seizure susceptibility and in seizure-induced plasticity after pharmacologic and genetic manipulation of the Fibroblast Growth Factor-2 system 239
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 237
Personalized needles for microinjections in the rodent brain 235
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 226
Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis 218
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 216
Delayed epileptogenesis in nociceptin/orphanin FQ-deficient mice 214
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 212
A potential reservoir of immature dopaminergic replacement neurons in the adult mammalian olfactory bulb 210
Dendritic targeting of mRNAs for plasticity genes in experimental models of temporal lobe epilepsy 209
Involvement of the neuropeptide orphanin FQ/nociceptin in kainate and kindling seizures and epileptogenesis 207
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 206
Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures 203
Gene Therapy Tools for Brain Diseases 203
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 201
Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis 198
Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis 197
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 196
Are the neurotrophic factors a suitable therapeutic target for the prevention of epileptogenesis? 195
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 194
Fibroblast Growth Factor-2 (FGF-2). 192
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 192
Implication of sestrin3 in epilepsy and its comorbidities 186
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 184
A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy 183
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: New evidence from rats and mice 181
Temporal lobe epilepsy model, neural stem cells and gene therapy 181
Mechanisms of action of CHF3381 in the forebrain 180
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 179
Properties and maturation of adult-generated dopaminergic neurons in the mammalian olfactory bulb 178
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 173
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 169
Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats 168
Herpes Simplex Virus Type 1 (HSV-1) Uracil-DNA Glycosylase: Functional Expression in Escherichia coli, Biochemical Characterization, and Selective Inhibition by 6-(p-n-Octylanilino)Uracil 167
Dynorphin and Nociceptin/Orphanin FQ (N/OFQ). 165
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 164
Different patterns of induction of fibroblast growth factor-2 and brain-derived neurotrophic factor messenger RNAs during kindling epileptogenesis, and development of a herpes simplex vector for fibroblast growth factor-2 gene transfer in vivo 159
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 146
Increased susceptibility to kainate seizures and decreased seizure-induced cell loss in transgenic mice overexpressing fibroblast growth factor-2 146
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 145
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 142
Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats during EEG Recordings 140
Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson’s disease 140
The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models 134
Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study 133
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation 129
Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development 129
Impairment of GABA release in the hippocampus at the time of the first spontaneous seizure in the pilocarpine model of temporal lobe epilepsy 129
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 127
Increased extracellular levels of glutamate in the hippocampus of chronically epileptic rats 123
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells 121
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 119
Gene therapy of the nervous system by herpes virus vectors 115
Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders 110
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells 108
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold? 107
Molecular approaches to inhibit HIV-1 tat expression and functions 102
null 97
null 94
null 94
null 93
Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements. 93
Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist 93
null 92
Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology 92
null 89
null 89
null 89
Possible Approaches of Gene Therapy of AIDS. 84
null 43
Totale 14.572
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.640
Totale 59.352
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021315 0 0 0 0 0 0 0 0 0 157 113 45
2021/2022742 31 94 61 24 27 28 47 42 20 48 69 251
2022/2023734 74 44 48 75 119 101 38 77 100 4 40 14
2023/2024881 41 46 41 12 48 222 89 97 66 62 50 107
2024/20252.055 55 47 152 114 215 264 86 109 324 157 253 279
2025/20265.197 654 194 397 756 830 416 699 274 498 479 0 0
Totale 14.572